Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:939971rdf:typepubmed:Citationlld:pubmed
pubmed-article:939971lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:939971lifeskim:mentionsumls-concept:C0750977lld:lifeskim
pubmed-article:939971lifeskim:mentionsumls-concept:C0042679lld:lifeskim
pubmed-article:939971lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:939971lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:939971lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:939971lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:939971pubmed:issue2lld:pubmed
pubmed-article:939971pubmed:dateCreated1976-9-25lld:pubmed
pubmed-article:939971pubmed:abstractTextSeventeen children with clinical evidence of a recurrent brain tumor were treated with vincristine 1.5 mg/sq m weekly for 12 weeks with doses on alternate weeks thereafter. Eight of the 16 patients who received four or more doses of vincristine showed significant objective responses; these included patients with high-and low-grade astrocytomas and patients with medulloblastoma. Six of the eight who responded remained asymptomatic for more than 2 years. The toxicity encountered was minimal except for seizures possibly related to vincristine in three children, who were able to resume treatment. Vincristine therapy results in long-term regression in a wide variety of pediatric brain tumors and causes little or no toxicity.lld:pubmed
pubmed-article:939971pubmed:languageenglld:pubmed
pubmed-article:939971pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:939971pubmed:citationSubsetAIMlld:pubmed
pubmed-article:939971pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:939971pubmed:statusMEDLINElld:pubmed
pubmed-article:939971pubmed:monthAuglld:pubmed
pubmed-article:939971pubmed:issn0022-3085lld:pubmed
pubmed-article:939971pubmed:authorpubmed-author:EvansA EAElld:pubmed
pubmed-article:939971pubmed:authorpubmed-author:RosenstockJ...lld:pubmed
pubmed-article:939971pubmed:authorpubmed-author:SchutLLlld:pubmed
pubmed-article:939971pubmed:issnTypePrintlld:pubmed
pubmed-article:939971pubmed:volume45lld:pubmed
pubmed-article:939971pubmed:ownerNLMlld:pubmed
pubmed-article:939971pubmed:authorsCompleteYlld:pubmed
pubmed-article:939971pubmed:pagination135-40lld:pubmed
pubmed-article:939971pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-H...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-I...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-B...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-S...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-C...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-C...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-F...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-M...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-A...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-M...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-N...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-V...lld:pubmed
pubmed-article:939971pubmed:meshHeadingpubmed-meshheading:939971-D...lld:pubmed
pubmed-article:939971pubmed:year1976lld:pubmed
pubmed-article:939971pubmed:articleTitleResponse to vincristine of recurrent brain tumors in children.lld:pubmed
pubmed-article:939971pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:939971pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:939971pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:939971lld:pubmed